Researchers explore outcomes for patients with high potassium - Medical Xpress
This story deserves to be shared
Send it to someone who'd care, or post it on your networks.
High levels of potassium in the blood, common in people on certain medications or with kidney disease, often come with no symptoms but can be deadly in severe cases. Because people with hyperkalemia, or high potassium, often "feel normal," their treating physicians must determine whether their condition can be safely managed outside the hospital or requires more urgent treatment in the emergency department. Researchers at Western University and London Health Sciences Centre Research Institute (LHSCRI) have shown that the risk of death was significantly lower among patients who were able to get to an emergency department within 24 hours of an abnormally high potassium reading.
This article is an excerpt. To read the full content, visit the original source. Medical Xpress
Related articles
WESTERN UNIVERSITY London researchers explore outcomes for patients with high potassium - Education News Canada
High levels of potassium in the blood, common in people on certain medications or with kidney disease, often come with no symptoms, but can be deadly in severe cases. Because people with hyperkalemia, or high potassium, often "feel normal," their treating physicians must determine whether their condition can be safely managed outside the hospital or requires more urgent treatment in the emergency department.
Bioengineer.org | Viral blips during HIV therapy are common and rarely signal treatment failure, Swedish study finds - European AIDS Treatment Group
Bioengineer.org news storyFor people living with HIV, modern antiretroviral therapy can suppress the virus to levels below what standard laboratory tests can detect. Yet some patients on long-term treatment experience a curious phenomenon: a single test result showing a small, transient amount of virus in the blood, followed by an immediate return to undetectable levels. These events, known as viral blips, have puzzled clinicians and researchers for years, raising questions about whether they represent harmless statistical noise, brief bursts of viral production from hidden reservoirs, or early warnings of impending treatment failure. A new nationwide Swedish study, published in BMC Infectious Diseases, offers one of the most comprehensive answers to date. Drawing on the Swedish national InfCareHIV cohort, researchers analyzed data from 4,210 treatment-naïve adults who began antiretroviral therapy from 1 January 2007 onward, with follow-up data extracted through 30 September 2020. The median observation time was 5.5 years, with some individuals followed for as long as 13.7 years.
European Medical Journal | HIV linked to early signs of heart dysfunction - European AIDS Treatment Group
European Medical Journal news storyPeople living with HIV may experience subtle changes in heart muscle function even when conventional measures of cardiac performance remain normal, according to findings from a systematic review and meta-analysis. Researchers identified significantly impaired global longitudinal strain (GLS) among people with HIV compared with HIV-uninfected individuals, despite preserved left ventricular ejection fraction (LVEF) in both groups. The findings suggest that speckle-tracking echocardiography (STE) could provide additional information about early myocardial dysfunction in this population. Read the full news story here.
Patient-centered financial navigation assistance helps reduce financial toxicity among cancer patients - Medical Xpress
Among cancer patients, the high financial cost of cancer care is a prevalent problem. This financial burden is also associated with potentially harmful behavioral strategies that patients might use to cope with costs, such as delaying or forgoing treatment and skipping medications. Collectively, researchers refer to this impact as financial toxicity.
0 comments
No comments yet. Be the first to share your thoughts!